March 13, 2015 by Chain Drug Review and Chain Drug Review
Rite Aid, Stefano Pessina, Walgreens Boots Alliance
CDR Blog
The “Walgreens looking to acquire Rite Aid” rumors have resurfaced following comments by Stefano Pessina, the billionaire investor and acting CEO of Walgreens Boots Alliance. A March 12 article by Reuters quoted Pessina, in remarks at the Retail Week Live conference in London, as saying that of potential deals to be made, “the next big
February 16, 2015 by Mark Baumgartner and Chain Drug Review
Alliance Boots, George Fairweather, Marco Pagni, Stefano Pessina, Tim McLevish, Wade Miquelon, Walgreens, Walgreens Boots Alliance
Issue 02-16-2015, News
DEERFIELD, Ill. — Two Alliance Boots executives were promoted in recent weeks to new positions with Walgreens Boots Alliance Inc. (WBA). George Fairweather, formerly group finance director at Alliance Boots, was named WBA executive vice president and global chief financial officer. And Marco Pagni, who was Alliance Boots’ group legal counsel and chief administrative officer,
January 19, 2015 by Mark Tosh and Chain Drug Review
Alliance Boots, CEO search, Greg Wasson, Jim Skinner, Nasdaq, Nasdaq MarketSite, Stefano Pessina, Walgreen Co., Walgreens Boots Alliance, WBA
2015, Issue 01-19-2015, News
NEW YORK — Walgreens Boots Alliance Inc.’s (WBA’s) top executives marked the close of a busy first week as a new company by ringing the opening bell January 9 at the Nasdaq Stock Market, where the company now trades under the “WBA” ticker symbol. Moments later, in an interview with financial network CNBC, executive vice chairman
January 9, 2015 by Chain Drug Review and Chain Drug Review
Greg Wasson, Jim Skinner, Nasdaq, Stefano Pessina, Walgreens, Walgreens Boots Alliance, WBA
Business, CDR Blog
Possibly lost in the fanfare surrounding the formal debut of Walgreens Boots Alliance, and its new home on the Nasdaq stock exchange, is the company’s new logo. Jim Skinner, executive chairman of WBA (the new stock symbol, by the way), told CNBC in the wake of the Nasdaq launch event in Manhattan that the company’s globe-shape logo
January 5, 2015 by Chain Drug Review
Alliance Boots, Dominic Murphy, Greg Wasson, Jim Skinner, KKR, merger, Stefano Pessina, Walgreens, Walgreens Boots Alliance, Walgreens shareholders, WBA
Business, Featured Articles, Retail News
DEERFIELD, Ill. – As expected, Walgreen Co. and Alliance Boots GmbH have finalized the second step of their two-part merger agreement following Walgreens shareholders’ approval earlier this week. Coming just before the new year, the completion of the deal announced in 2012 reorganizes Walgreens into a subsidiary of a new holding company, Walgreens Boots Alliance
January 5, 2015 by Mark Tosh and Chain Drug Review
Alliance Boots, Greg Wasson, James Skinner, Stefano Pessina, Walgreens, Walgreens Boots Alliance, William Foote
2015, Business, Issue 01-05-2015, News
DEERFIELD, Ill. — The New Year ushered in the beginning of a new era at Walgreen Co., which is scheduled to complete the second and final step of its merger with Alliance Boots GmbH in the first quarter. And this new era for Walgreens Boots Alliance will get under way without the presence of longtime
January 5, 2015 by Jeffrey Woldt and Chain Drug Review
Alliance Boots, CEO, chief executive officer, drug chain, Greg Wasson, Jeffrey Woldt, retail pharmacy, Stefano Pessina, Walgreens
2015, Issue 01-05-2015, Opinion
When the history of Walgreen Co. is written, Greg Wasson, who last month announced that he would step down as chief executive officer of the drug chain upon completion of its merger with Alliance Boots, will be seen as one of the company’s most consequential leaders. A product of the Walgreens system who joined the